Current Report Filing (8-k)
May 16 2022 - 9:31AM
Edgar (US Regulatory)
0001353406
false
0001353406
2022-05-16
2022-05-16
iso4217:USD
xbrli:shares
iso4217:USD
xbrli:shares
UNITED
STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM
8-K
CURRENT
REPORT
Pursuant
to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date
of Report (Date of Earliest Event Reported): May 16,
2022
REDHAWK
HOLDINGS CORP.
(Exact
name of registrant as specified in its charter)
Nevada |
000-54323 |
20-3866475 |
(State or other jurisdiction
of incorporation) |
(Commission File Number) |
(I.R.S. Employer Identification
No.) |
|
|
|
100
Petroleum Drive Suite 200, Lafayette,
Louisiana 70508 |
(Address
of principal executive offices) (Zip Code) |
Registrant’s
telephone number, including area code: (337)
269-5933
Check
the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under
any of the following provisions:
☐ |
Written communications
pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
|
|
☐ |
Soliciting material pursuant
to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
|
|
☐ |
Pre-commencement communications
pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
|
|
☐ |
Pre-commencement communications
pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Securities
registered pursuant to Section 12(b) of the Act: None.
Indicate
by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405
of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging
growth company ☐
If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
The
Registrant confirmed today that it is in discussions with a leading healthcare provider (“Provider”) of pharmaceutical care
and clinical services in the United States with the mutual objective (i) to reach an agreement to install the Registrant’s SANDD
Pro™ needle incineration devices in each of the Provider’s pharmacies and clinics in order to reduce the Provider’s
needle disposal costs and eliminate incidents of workplace needle stick injuries; and (ii) to reach an agreement for the Provider to
offer to the public in each of its pharmacies the over-the-counter “white label” sale of the Registrant’s SANDD
mini™.
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this Report to be signed on its behalf by
the undersigned, hereunto duly authorized.
|
REDHAWK HOLDINGS CORP. |
|
|
Date: May 16, 2022 |
By: |
/s/
G. Darcy Klug |
|
|
G. Darcy Klug |
|
|
Chief Financial Officer |